Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells
Recurrent mutations at key lysine residues in the histone variant H3.3 are thought to play an etiologic role in the development of distinct subsets of pediatric gliomas and bone and cartilage cancers. H3.3K36M is one such mutation that was originally identified in chondroblastomas, and its expressio...
Main Authors: | Saumya M. Sankaran, Or Gozani |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-11-01
|
Series: | Epigenetics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15592294.2017.1377870 |
Similar Items
-
Structural and functional specificity of H3K36 methylation
by: Ulysses Tsz Fung Lam, et al.
Published: (2022-05-01) -
SETD2-H3K36ME3: an important bridge between the environment and tumors
by: Jiahui He, et al.
Published: (2023-06-01) -
H3K36me3, message from chromatin to DNA damage repair
by: Zhongxing Sun, et al.
Published: (2020-01-01) -
Loss of NSD2 causes dysregulation of synaptic genes and altered H3K36 dimethylation in mice
by: Shiori Kinoshita, et al.
Published: (2024-02-01) -
A histone H3.3K36M mutation in mice causes an imbalance of histone modifications and defects in chondrocyte differentiation
by: Shusaku Abe, et al.
Published: (2021-10-01)